# Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients

> **NCT02359123** · NA · COMPLETED · sponsor: **Cannabics Pharmaceuticals Inc.** · enrollment: 24 (actual)

## Conditions studied

- Cancer Cachexia
- Atypical Anorexia Nervosa

## Interventions

- **OTHER:** Cannabics capsules

## Key facts

- **NCT ID:** NCT02359123
- **Lead sponsor:** Cannabics Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2018-04-01
- **Final completion:** 2018-04-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02359123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02359123, "Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT02359123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*